Recro Pharma Inc. (REPH) Climbed 5.16% or 0.3 To Price $6.12 On Friday

Recro Pharma Inc. (REPH) climbed 5.16% or 0.3 to $6.12. It is nearly 68169 shares traded, which is 62.54% compare to the average total volume 109003. The market cap of REPH is $126.79 million. The year to date change is -30.46%. The 52 week price range is from $4.78 to $13.05. Price of REPH have changed -1.19% during last week. It have changed 8.99% over last month, -46.46% over last 3 months, -29.88% over last 6 months and -20.82% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for REPH is 5.41. It is -11.60% below current price. The 200-day Moving Averages for REPH is 8.56. It is 39.87% above current price. The 52-week High is 13.05. It is 113.24% from the current price. The 52-week Low is 4.78. It is -21.90% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of REPH is 4.49 on 2018-07-31. Short % to float is 2.42%. There are some statistics of REPH. It is has market cap $126.79 million. The share outstanding is 20.72 million. The average volume is 109003. The revenue is 17.11M. It has 41.31M cash and 24.89M in debt. The gross profit is 10.23M. The percent of top 15 Institution holding is 54.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of REPH is -143.14%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of REPH is -33.29%.


Share this post